A BD Audit is an independent review and analysis of your entire out-licensing value chain. During the course of an Audit, we compare your current out-licensing process with the ideal process.
Recommendations are based on our assessment of your current process versus the ideal process…which we then turn into actionable steps to improve you process and increase the likelihood of securing a partnership.
It is divided into four segments:
The Asset refers to all of the elements which describe the opportunity, such as presentations, development plans, budgets, and reimbursement. We tackle issues such as:
The Outreach Plan is the roadmap for navigating the process. Key questions include:
Execution is the actual outreach activity. We provide suggestions on how to track and report your progress.
Follow Up are those activities performed after a prospective licensing partner becomes engaged. We provide suggestions on
During the course of our analysis, you will receive interim and final versions of a detailed report summarizing our findings.
Importantly, our recommendations are
How Long Does This Take?
Depending on the complexity of the case, we typically complete our audits in one month. We can also extend the process and assist you in improving your process by developing new presentations, reorganizing the data room, and even perform the market research necessary to enhance the information supporting your asset opportunity.
Why Lacerta Bio?
Founded in 2010, Lacerta Bio is totally dedicated to pharma and biotech business development. We have worked on many successful licensing projects, and we have seen many of them fail simply because they are not presented well. We can help change that.
We understand what it takes to grab the attention of the multinational pharmaceutical companies, and to start the dialogue which may lead to a licensing deal.
Contact us today to learn more!